Acrodermatitis atrophicans references
Aberer E, Klade H. Cutaneous manifestations of Lyme borreliosis. Infection. 1991 Jul-Aug;19(4):284-6. [PubMed]
Busch U, Hizo-Teufel C, Böhmer R, Fingerle V, Rössler D, Wilske B, Preac-Mursic V. Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis. Scand J Infect Dis. 1996;28(6):583-9. [PubMed]
Schempp C, Bocklage H, Lange R, Kölmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100(5):717- 20. [PubMed]
Wienecke R1, Zöchling N, Neubert U, Schlüpen EM, Meurer M, Volkenandt M. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol. 1994;103(1):19-22. [PubMed]
Some definitions of Terminology
✓ The secondary stage results from the dissemination of Borrelia during the early latent stage.
✓ The late stage is considered chronic if the duration is more than six months.
✓ ** (double red asterisks) indicates possibility of fatality from the condition
© Copyright 2017. Global Network on Institutional Discrimination and Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes All Rights Reserved